Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Left atrial enlargement: a cause of stroke?
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
Superantigens
Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia.
What's the Purpose of Rounds? A Qualitative Study Examining the Perceptions of Faculty and Students.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med. 2010 Sep 30; 363(14):1313-23.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Child
Child, Preschool
Cyclophosphamide
Doxorubicin
Etoposide
Humans
Infant
Intention to Treat Analysis
Neoplasm Staging
Neuroblastoma
Prospective Studies
Survival Analysis
Treatment Outcome
authors with profiles
Susan Cohn